Understanding the joint effects of EBV and vitamin D in MS

Abstract

Get full access to this article

View all access options for this article.

References

Ascherio

Munger

. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007; 61: 288–299.

Ascherio

Munger

Lunemann

. The initiation and prevention of multiple sclerosis. Nat Rev Neurol 2012; 8: 602–612.

Salzer

Nystrom

Hallmans

. Epstein–Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples. Mult Scler J 2013; [Epub ahead of print].

Salzer

Hallmans

Nystrom

. Vitamin D as a protective factor in multiple sclerosis. Neurology 2012; 79: 2140–2145.

Munger

Levin

O’Reilly

. Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: A prospective study among United States military personnel. Mult Scler J 2011; 17: 1185–1193.

Banwell

Bar-Or

Arnold

. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: A prospective national cohort study. Lancet Neurol 2011; 10: 436–445.

Disanto

Handel

Damoiseaux

. Vitamin D supplementation and antibodies against the Epstein–Barr virus in multiple sclerosis patients. Mult Scler J 2013; [Epub ahead of print].